Clinical trial
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
NCT06363123
Study timeline
Study start (actual)2024-03-29Date precision: day
Registry last updated2024-04-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Breast Cancerunresolved
Colorectal Cancerunresolved
Thyroid Cancerunresolved
Gastric Cancerunresolved
Cervical Cancerunresolved
Liver Cancerunresolved
Pancreatic Cancerunresolved
Cholangiocarcinomaunresolved
Prostate Cancerunresolved
Esophageal Cancerunresolved
Ovarian Cancerunresolved
Renal Cell Carcinomaunresolved
Interventions
Sponsors & collaborators
Beijing Friendship Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06363123 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.